Author: Bennett, Ryan P.; Finch, Courtney L.; Postnikova, Elena N.; Stewart, Ryan A.; Cai, Yingyun; Yu, Shuiqing; Liang, Janie; Dyall, Julie; Salter, Jason D.; Smith, Harold C.; Kuhn, Jens H.
Title: A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures Cord-id: mv0vkwcr Document date: 2020_12_31
ID: mv0vkwcr
Snippet: Filoviruses, such as Ebola virus and Marburg virus, are of significant human health concern. From 2013 to 2016, Ebola virus caused 11,323 fatalities in Western Africa. Since 2018, two Ebola virus disease outbreaks in the Democratic Republic of the Congo resulted in 2354 fatalities. Although there is progress in medical countermeasure (MCM) development (in particular, vaccines and antibody-based therapeutics), the need for efficacious small-molecule therapeutics remains unmet. Here we describe a
Document: Filoviruses, such as Ebola virus and Marburg virus, are of significant human health concern. From 2013 to 2016, Ebola virus caused 11,323 fatalities in Western Africa. Since 2018, two Ebola virus disease outbreaks in the Democratic Republic of the Congo resulted in 2354 fatalities. Although there is progress in medical countermeasure (MCM) development (in particular, vaccines and antibody-based therapeutics), the need for efficacious small-molecule therapeutics remains unmet. Here we describe a novel high-throughput screening assay to identify inhibitors of Ebola virus VP40 matrix protein association with viral particle assembly sites on the interior of the host cell plasma membrane. Using this assay, we screened nearly 3000 small molecules and identified several molecules with the desired inhibitory properties. In secondary assays, one identified compound, sangivamycin, inhibited not only Ebola viral infectivity but also that of other viruses. This finding indicates that it is possible for this new VP40-based screening method to identify highly potent MCMs against Ebola virus and its relatives.
Search related documents:
Co phrase search for related documents- ltr promoter and luciferase reporter: 1
- luciferase activity and lysine residue: 1
- luciferase activity and lysis buffer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- luciferase activity and madison promega: 1, 2, 3, 4, 5, 6
- luciferase expression and luminescence cell: 1
- luciferase expression and lysis buffer: 1
- luciferase expression and madison promega: 1
- luciferase plate and lysis buffer: 1, 2, 3, 4, 5
- luciferase plate and madison promega: 1
- luciferase reporter and lysine residue: 1
- luciferase reporter and lysis buffer: 1, 2, 3, 4, 5, 6, 7, 8
- luciferase reporter and madison promega: 1, 2, 3, 4
- luciferase reporter gene and lysis buffer: 1
- luciferase signal and luminescence cell: 1
- luciferase signal and lysis buffer: 1, 2, 3
- luciferase substrate and lysis buffer: 1, 2, 3, 4
- luciferase substrate and madison promega: 1
- lysis buffer and madison promega: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date